E
ClearPoint Neuro, Inc. CLPT
$10.64 $0.141.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -32.42% -45.34% -16.61% -3.43% 37.49%
Total Depreciation and Amortization 35.21% -29.54% 11.08% 17.02% 36.58%
Total Amortization of Deferred Charges 50.00% -- -100.00% 57.14% 0.00%
Total Other Non-Cash Items 70.10% 56.48% 0.84% -6.35% -23.30%
Change in Net Operating Assets 214.53% -69.05% 57.95% 149.36% 30.36%
Cash from Operations 4.35% -60.73% -6.33% 33.24% 47.43%
Capital Expenditure -- -- -1,152.38% 94.89% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -39.89% 94.89% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1,150.69% -99.87% -36.98% -- -8.28%
Repurchase of Common Stock -178.13% -764.24% -127.03% 32.97% -66.23%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 19,885.63% -108.48% -76.13% -10,956.04% -32.49%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,269.62% -163.19% -22.21% -431.20% -153.68%